Reposted by Eliza James
Researchers studied 200 people with Long COVID and found Viusid, an antioxidant and immune-modulating supplement, improved brain fog, fatigue, sleep, mood and breathing symptoms versus placebo after 210 days.
Larger trials are needed.
www.eurekaselect.com/article/158201
eurekaselect.com
Effects of Viusid in Long COVID: A Randomized Double-Blind Placebo-Controlled Trial
Introduction: Long COVID syndrome (LCS) is characterized by persistent neurological, respiratory, and systemic symptoms following SARS-CoV-2 infection, with limited effective treatments available. Viu...